63,397 Shares in DENTSPLY SIRONA Inc. $XRAY Purchased by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 63,397 shares of the medical instruments supplier’s stock, valued at approximately $805,000.

Several other large investors have also recently added to or reduced their stakes in the company. AQR Capital Management LLC grew its holdings in shares of DENTSPLY SIRONA by 109.8% during the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after purchasing an additional 6,970,086 shares in the last quarter. Norges Bank acquired a new position in shares of DENTSPLY SIRONA in the second quarter valued at $39,700,000. Goldman Sachs Group Inc. raised its stake in shares of DENTSPLY SIRONA by 827.3% in the first quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after purchasing an additional 2,172,343 shares in the last quarter. Brickwood Asset Management LLP lifted its position in DENTSPLY SIRONA by 5,515.8% in the third quarter. Brickwood Asset Management LLP now owns 1,524,074 shares of the medical instruments supplier’s stock worth $19,340,000 after purchasing an additional 1,496,935 shares during the period. Finally, Vanguard Group Inc. boosted its stake in DENTSPLY SIRONA by 4.1% during the third quarter. Vanguard Group Inc. now owns 22,006,576 shares of the medical instruments supplier’s stock worth $279,263,000 after buying an additional 869,566 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 0.5%

Shares of NASDAQ:XRAY opened at $12.80 on Tuesday. DENTSPLY SIRONA Inc. has a 52 week low of $9.85 and a 52 week high of $17.18. The company has a debt-to-equity ratio of 1.50, a quick ratio of 1.03 and a current ratio of 1.51. The company’s fifty day moving average is $12.66 and its 200-day moving average is $12.44. The company has a market capitalization of $2.56 billion, a PE ratio of -4.27, a P/E/G ratio of 1.49 and a beta of 0.97.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, February 26th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.85% and a negative net margin of 16.25%.The firm had revenue of $961.00 million during the quarter, compared to the consensus estimate of $926.40 million. During the same period in the previous year, the company posted $0.26 EPS. The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 annualized dividend and a dividend yield of 5.0%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -21.33%.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on XRAY. Barrington Research boosted their price target on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a report on Monday, March 2nd. Wells Fargo & Company raised their price objective on shares of DENTSPLY SIRONA from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Friday, February 27th. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $17.00 to $16.00 and set a “buy” rating on the stock in a research report on Tuesday, February 3rd. Robert W. Baird increased their price target on shares of DENTSPLY SIRONA from $12.00 to $14.00 and gave the stock a “neutral” rating in a research report on Friday, February 27th. Finally, Mizuho raised their price target on shares of DENTSPLY SIRONA from $14.00 to $16.00 and gave the stock a “neutral” rating in a research note on Monday, March 2nd. Three investment analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $14.42.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director James D. Forbes purchased 5,000 shares of the firm’s stock in a transaction that occurred on Monday, March 9th. The shares were acquired at an average cost of $12.48 per share, for a total transaction of $62,400.00. Following the transaction, the director directly owned 10,000 shares in the company, valued at approximately $124,800. The trade was a 100.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Gregory T. Lucier purchased 27,555 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were acquired at an average cost of $14.24 per share, with a total value of $392,383.20. Following the completion of the acquisition, the director directly owned 27,555 shares in the company, valued at approximately $392,383.20. This represents a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders bought 70,000 shares of company stock valued at $956,437 in the last quarter. 0.52% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.